Walgreens Boots Alliance EBIT

Walgreens Boots Alliance posts a EBIT of $-4.1B as of May 2025. That compares with $-340M in the prior-year period — down 1091.2% year over year. That is below the Healthcare sector average of $23B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Walgreens Boots Alliance's EBIT was $-340M. The latest reading is $-4.1B — a 1091.2% year-over-year decrease (period ending May 2025). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a EBIT near $23B is typical. Walgreens Boots Alliance's $-4.1B is lower that level. That is roughly 117.6% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Walgreens Boots Alliance's financial statement story. At $-4.1B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for WBA's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $23B), and (3) consistency with growth and profitability. This page covers the first two; Walgreens Boots Alliance's other metric pages and overview cover the third.